Nanoparticles can be functionalized with ligands that specifically bind to molecules found in plaque. These ligands can be antibodies, peptides, or small molecules that have a high affinity for plaque components such as oxidized LDL or inflammatory markers like VCAM-1. This targeted approach ensures that the nanoparticles accumulate primarily in the plaque, improving the precision of both diagnostic and therapeutic interventions.
